Peptides
Glutathione: skin claims, route differences, and injection safety
Glutathione is a small molecule made from three amino acids and used by cells in antioxidant and detoxification chemistry. It appears alongside peptides in the catalog, but its normal biological role does not mean extra injected glutathione improves energy, skin, or aging outcomes. Form and route matter. [1,2]
What does human research show?
A randomized, double-blind study in 60 healthy students compared oral glutathione with placebo over four weeks. The researchers reported reduced pigmentation at some measured skin sites, but the effect was limited and short-term. This is not evidence that injections brighten skin or that a different product works. [1]
Another small oral study in healthy volunteers used a different schedule and found no significant improvement in measured oxidative-stress markers. Antioxidant blood chemistry and meaningful clinical outcomes are different endpoints. [2]
Why does injection safety deserve attention?
In August 2026, FDA warned compounders not to use dietary-supplement-grade glutathione for sterile injections. FDA said it was aware of at least 30 patients with adverse events after IV glutathione, alone or with other ingredients, in an investigation involving an inappropriate source ingredient. Earlier FDA investigations also linked injectable products to concerning endotoxin levels. These findings highlight why ingredient and sterility verification are essential; they do not imply every formulation has the same risk. [3,4]
STUDIED AMOUNT
How much?
SOURCE CONTEXT
What it refers to
studied oral amount in the small pigmentation trial.
500 mg by mouth daily for four weeks — studied oral amount in the small pigmentation trial. The amount was split into two daily capsule doses. It is not a proven injection dose or a general antioxidant recommendation. [1]
Read detailed dosing notes
A small IV skin-lightening study has been discussed by regulators, but its combined ingredients and weak design do not establish a standard IV amount. No safe and effective injection dose can be derived for the catalog vial. The 1,200 mg on that vial is total labeled content, not a tested treatment schedule. [3,4]
Sources & further reading
- Arjinpathana and Asawanonda (2012). Randomized oral-glutathione pigmentation trial (opens in a new tab)pubmed.ncbi.nlm.nih.gov
- Allen and Bradley (2011). Oral glutathione and oxidative-stress biomarkers (opens in a new tab)pmc.ncbi.nlm.nih.gov
- FDA (2026). Do not use dietary supplement grade glutathione for injectables (opens in a new tab)www.fda.gov
- FDA. Concerns with dietary ingredient glutathione in sterile injectables (opens in a new tab)www.fda.gov